Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022

from Medical Digest & Congress Report · host Medical Congress News

Professor Carl Orringer was a co-chair of a recent symposium at the European Atherosclerosis Society 2022 session in Milan. The topic of the discussion was the potential role of the injectable therapies to prevent cardiovascular disease. Video: https://congressreport.eu/scientific-contents/interview:who-needs-injectable-therapies-cholesterol-lowering-or-statins-and-ezetimibe-are-enough-cvd-prevention

Episode metadata supplied by the publisher feed · Published Jun 15, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022

0:00 6:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on June 15, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!